Jeff Evanson

Companies

• Outlook Therapeutics, Inc.Chief Commercial Officer Dec 4, 2018 to Mar 22, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• OTOutlook Therapeutics, Inc. OTLK808,459 shares²$410.8K at $0.51Mar 7, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 7, 2024Bought 62,484 shares at $0.42 of Outlook Therapeutics, Inc.²
• Jan 20, 2023Sold 267,000 shares at $1.11 of Outlook Therapeutics, Inc.³
• Jan 19, 2023Sold 103,255 shares at $1.22 of Outlook Therapeutics, Inc.⁴
• Jan 18, 2023Sold 33,738 shares at $1.25 of Outlook Therapeutics, Inc.⁴
• Jan 17, 2023Sold 27,162 shares at $1.31 of Outlook Therapeutics, Inc.⁴
• Dec 3, 2021Bought 35,200 shares at $1.34 of Outlook Therapeutics, Inc.⁵